197 related articles for article (PubMed ID: 35323111)
1. Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike.
Díaz-Salinas MA; Li Q; Ejemel M; Yurkovetskiy L; Luban J; Shen K; Wang Y; Munro JB
Elife; 2022 Mar; 11():. PubMed ID: 35323111
[TBL] [Abstract][Full Text] [Related]
2. Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike.
Díaz-Salinas MA; Li Q; Ejemel M; Yurkovetskiy L; Luban J; Shen K; Wang Y; Munro JB
bioRxiv; 2021 Nov; ():. PubMed ID: 34790979
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
4. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
6. Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2.
Choi KE; Kim JM; Rhee J; Park AK; Kim EJ; Kang NS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445414
[TBL] [Abstract][Full Text] [Related]
7. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
[TBL] [Abstract][Full Text] [Related]
8. Computational Insights into the Conformational Accessibility and Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-Converting Enzyme 2.
Peng C; Zhu Z; Shi Y; Wang X; Mu K; Yang Y; Zhang X; Xu Z; Zhu W
J Phys Chem Lett; 2020 Dec; 11(24):10482-10488. PubMed ID: 33274945
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
[TBL] [Abstract][Full Text] [Related]
10. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
11. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
[TBL] [Abstract][Full Text] [Related]
12. Dynamics and electrostatics define an allosteric druggable site within the receptor-binding domain of SARS-CoV-2 spike protein.
Bhattacharjee S; Bhattacharyya R; Sengupta J
FEBS Lett; 2021 Feb; 595(4):442-451. PubMed ID: 33449359
[TBL] [Abstract][Full Text] [Related]
13. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
Huang SW; Miller SO; Yen CH; Wang SF
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
[TBL] [Abstract][Full Text] [Related]
14. S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study.
Rahnama S; Azimzadeh Irani M; Amininasab M; Ejtehadi MR
Sci Rep; 2021 Jul; 11(1):15162. PubMed ID: 34312429
[TBL] [Abstract][Full Text] [Related]
15. Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.
Basit A; Ali T; Rehman SU
J Biomol Struct Dyn; 2021 Jul; 39(10):3605-3614. PubMed ID: 32396773
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Assay for Identifying Diverse Antagonists of the Binding Interaction between the ACE2 Receptor and the Dynamic Spike Proteins of SARS-CoV-2.
Sammons RM; Bohanon AL; Kowtha A; Dejong A; Cho EJ; Kaoud TS; Dalby KN
ACS Infect Dis; 2022 Nov; 8(11):2259-2270. PubMed ID: 36315931
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
Ge J; Zhang S; Zhang L; Wang X
Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
[TBL] [Abstract][Full Text] [Related]
18. Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor.
Taka E; Yilmaz SZ; Golcuk M; Kilinc C; Aktas U; Yildiz A; Gur M
J Phys Chem B; 2021 Jun; 125(21):5537-5548. PubMed ID: 33979162
[TBL] [Abstract][Full Text] [Related]
19. Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain.
Low-Gan J; Huang R; Kelley A; Jenkins GW; McGregor D; Smider VV
Biochem J; 2021 Oct; 478(19):3671-3684. PubMed ID: 34558627
[TBL] [Abstract][Full Text] [Related]
20. Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.
Kumawat N; Tucs A; Bera S; Chuev GN; Valiev M; Fedotova MV; Kruchinin SE; Tsuda K; Sljoka A; Chakraborty A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
